Oncology & Hematology Coding Alert

Reader Questions:

Inject 25 Into Some 90772 Claims

Question: We recently received a denial for 90772 from Medicare when we reported it with an office visit. Should we be doing something differently?


Michigan Subscriber
Answer: The solution is properly applying modifier 25 (Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure or other service).

Example: The oncologist provides an E/M service that merits 99213 (Office or other outpatient visit for the evaluation and management of an established patient ...) and administers an injection (90772, Therapeutic, prophylactic, or diagnostic injection [specify substance or drug]; subcutaneous or intramuscular).

Append 25 to the E/M visit.

Note: If the E/M only merits 99211 (Office or other outpatient visit for the evaluation and management of an established patient, that may not require the presence of a physician ...), you shouldn't report it with the injection to Medicare. (Medicare Claims Processing Manual Chapter 12, Section 30.5-30.6, www.cms.hhs.gov/manuals/downloads/clm104c12.pdf.)
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All